In the setting of paired tumor/normal sequencing inclusive of broad cancer-associated gene content and allowing for comprehensive analysis of the CHEK2 gene, variant classification may improve, further delineating which CHEK2 variants may impact cancer risk [64,65,66]. This evidence concerns the gene CHEK2 and neoplasm.